查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676821

牲畜疼痛缓解和预防市场：类型、来源、给药方式、目标类型 - 2025-2030 年全球预测

Pain Relief & Prevention in Livestock Market by Type, Source, Method of Administration, Target Species - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计牲畜疼痛缓解和预防市场价值在 2024 年将达到 36.8 亿美元，2025 年将达到 39.5 亿美元，到 2030 年将达到 59.4 亿美元，复合年增长率为 8.30%。

主要市场统计数据
基准年 2024 年 36.8亿美元
预计 2025 年 39.5亿美元
预测年份 2030 59.4亿美元
复合年增长率（%） 8.30％

在不断发展的动物保健领域，农场动物的疼痛缓解和预防方面已经取得了巨大进展。随着人们对动物福利认识的不断提高以及对安全有效治疗的需求不断增长，该行业正在稳步向更全面、更具创新性的解决方案迈进。本摘要深入探讨了牲畜疼痛管理策略的现状，并强调了重塑该领域的挑战、机会和方法。

相关人员正在采取积极主动的方式进行研究和开发，以满足对不仅可以缓解疼痛还可以预防疼痛的治疗方法的需求。随着经济和道德要求推动行业变革，人们的重点是更有针对性的干预措施和科学突破，以实现更健康的牲畜种群和永续的农业。

本次简报探讨了产业的变革倡议和推动市场动态的关键细分见解。它还深入研究了这些技术突破的地理位置，检验了引领这项变革的公司，并为寻求在日益复杂的市场中保持竞争力的行业领导者提供了可行的建议。

改变牲畜疼痛缓解和预防市场

近年来，在新的科学研究、技术创新和不断发展的法律规范的推动下，牲畜疼痛管理领域发生了重大变化。这些变化正在加速采用更专业和有效的疼痛缓解和预防方法。生物技术和资料分析的进步使医生能够更准确地诊断疼痛状况，从而改善预防和治疗的护理策略。

从传统的症状治疗转向对疼痛病因的更深入理解是推动改变的重要因素。如今，创新治疗方法不仅旨在解决直接的疼痛症状，还旨在解决急性和慢性不适的根本原因。这种综合方法以更好的诊断和精准医疗为基础，进而支持更有针对性的治疗管理。

此外，产业相关人员越来越重视预防措施作为畜牧业生产系统健康管理的基本要素。世界各地的监管机构都在倡导更高的福利标准，并根据新兴的科学证据调整政策。这些监管改革以及消费者对动物福利的期望变化，正在鼓励公司大力投资研发和新产品开发。

这些变革趋势要求从一刀切的方法转向更细分的、资料主导的方法。透过接受这些变化，动物健康决策者可以优化治疗结果，降低治疗成本并提高农场和生产设施的整体生产力。

牲畜疼痛缓解解决方案的关键细分市场分析

牲畜疼痛缓解和预防市场高度细分，多种标准构成了策略决策的支柱。关键的细分技术是基于疼痛类型，透过急性疼痛和慢性疼痛的视角来审视市场。区分这两类动物可以让行业专业人士设计有针对性的干预措施，以满足那些突然感到疼痛的动物和那些长期感到不适的动物的特定需求。

另一层细分突显了疼痛的原因，深入研究疾病相关疼痛、损伤相关疼痛、程序性疼痛、手术相关疼痛等。这样的观点不仅有利于更精细地分析治疗效果，而且有助于识别与各种原因相关的疼痛模式。例如，与手术和外科手术相关的疼痛的治疗通常需要专门的配方和给药方法，以确保快速起效和持续疗效。

市场区隔的另一个考虑因素是管理方法。给药方法包括口服、肠胃外和局部给药机制。具体来说，肠外给药又细分为肌肉给药和静脉注射，每种给药都有各自的临床指征和操作挑战。这种细分对于根据动物的具体情况定制治疗方法至关重要，可以平衡给药的简易性、生物利用度和成本效益等因素。

最后，根据目标动物种类进行细分对于客製化止痛产品至关重要。市场分析显示，牛、家禽、绵羊/山羊和猪等不同动物物种有不同的特征。不同动物物种不仅对疼痛介入有不同的生理反应，还需要独特的剂型和治疗方法以确保安全性和有效性。这种细分方法将帮助治疗者和产品开发人员微调特定物种的治疗计划，同时仍能适应畜牧业管理的整体需求。

这种细分见解凸显了牲畜止痛市场市场的复杂性，以及需要创新、精确和客製化的解决方案来满足相关人员的多样化需求。透过深入了解这些领域，公司和研究人员可以更好地克服挑战并找到动物健康领域的成长和改善机会。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 对不含压力相关疾病的高品质畜产品的需求不断增加
      • 扩大畜牧业生产以满足不断增长的世界人口的饮食需求
      • 提高世界各地对动物福利标准和道德养殖实践的认识
    • 限制因素
      • 区域法规影响产品分销
    • 机会
      • 创新智慧诊断工具，确保及早发现和管理牲畜疼痛
      • 利用天然和有机止痛药解决牲畜健康问题
    • 任务
      • 难以评估和测量牲畜的疼痛程度，导致有效治疗困难
  • 市场区隔分析
    • 类型：牲畜急性疼痛加剧，需速效止痛药或局部麻醉药
    • 目标物种：由于与喙修剪和运输过程中的压力等实践相关的福利问题，增加家禽的疼痛管理
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 牲畜疼痛缓解和预防市场（按类型）

  • 急性疼痛
  • 慢性疼痛

7. 牲畜疼痛缓解和预防市场（依来源）

  • 与疾病相关的疼痛
  • 受伤引起的疼痛
  • 与手术相关的疼痛
  • 手术疼痛

8. 牲畜疼痛缓解及预防市场（依给药方式）

  • 口服
  • 肠外
    • 肌肉注射
    • 静脉
  • 话题

第九章。

  • 牛
  • 家禽
  • 绵羊和山羊
  • 猪

10. 美洲牲畜疼痛缓解与预防市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区牲畜疼痛缓解及预防市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲牲畜疼痛缓解和预防市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • AdvaCare Pharma USA
  • Bimeda Holdings Limited
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Covetrus, Inc.
  • Dechra Pharmaceuticals Limited
  • Elanco Animal Health Incorporated
  • HUVEPHARMA EOOD
  • IDEXX Laboratories, Inc
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Patterson Vet Supply, Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Vetpro Healthcare
  • VIRBAC Animal Health India Private Ltd
  • Zoetis Services LLC
Product Code: MRR-3D150775E700

The Pain Relief & Prevention in Livestock Market was valued at USD 3.68 billion in 2024 and is projected to grow to USD 3.95 billion in 2025, with a CAGR of 8.30%, reaching USD 5.94 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.68 billion
Estimated Year [2025] USD 3.95 billion
Forecast Year [2030] USD 5.94 billion
CAGR (%) 8.30%

The evolving landscape of animal health management has seen significant advancements in pain relief and prevention for livestock. With a heightened awareness of animal welfare and an ever-increasing demand for safe and effective treatments, the industry has steadily moved towards more comprehensive and innovative solutions. This summary provides a deep insight into the current state of pain management strategies for livestock, highlighting the challenges, opportunities, and methodologies that are reshaping the field.

Fostering a proactive approach, stakeholders are aligning their research and development with the need for therapies that not only alleviate pain but also prevent its onset. As economic and ethical imperatives drive change in the industry, the focus has turned to more targeted interventions and scientific breakthroughs that ensure healthier livestock populations and more sustainable agricultural practices.

In this briefing, we explore the transformative shifts within the industry and the critical segmentation insights that drive market dynamics. We also delve into the geographical distribution of these innovations, examine the companies spearheading these changes, and offer actionable recommendations for industry leaders who are committed to maintaining a competitive edge in an increasingly complex market.

Transformative Shifts in the Livestock Pain Management Landscape

Recent years have witnessed transformative shifts in the pain management landscape for livestock, spurred by emerging scientific research, technological innovations, and evolving regulatory frameworks. These shifts have collectively accelerated the adoption of more specialized and effective approaches to pain relief and prevention. Advances in biotechnologies and data analytics are enabling practitioners to diagnose pain conditions more accurately, leading to improved care strategies that are both preventive and curative in nature.

The movement from traditional symptomatic treatments toward a more nuanced understanding of pain etiology is a critical change driver. Innovative therapies are now being designed to address not only the immediate pain symptoms but also the underlying causes of acute and chronic discomfort. This integrated approach is supported by better diagnostics and precision medicine, which in turn supports a more targeted method of treatment administration.

Furthermore, industry stakeholders are increasingly focusing on preventive measures as a fundamental element of health management in livestock systems. Regulatory bodies around the globe are advocating for higher welfare standards, aligning policies with emerging scientific evidence. Such regulatory reforms, along with shifts in consumer expectations regarding animal welfare, have pushed companies to invest heavily in research and new product development.

These transformative trends have necessitated a shift from a one-size-fits-all approach to a more segmented, data-driven methodology. By embracing these changes, decision-makers in the animal health space are better positioned to optimize outcomes, reduce treatment costs, and enhance overall productivity on farms and production facilities.

Key Segmentation Insights in Livestock Pain Relief Solutions

The market for pain relief and prevention in livestock is highly segmented, with diverse criteria forming the backbone of strategic decisions. One critical segmentation approach is based on the type of pain, where the market is examined through the lens of both acute pain and chronic pain. By distinguishing between these two categories, industry professionals can design targeted interventions that cater to the specific needs of animals experiencing sudden pain versus those suffering from prolonged discomfort.

Another layer of segmentation emphasizes the source of pain, with a detailed study across disease-related pain, injury-related pain, procedural pain, and surgical pain. This perspective not only facilitates a more refined analysis of treatment efficacy but also aids in identifying pain patterns linked to various causes. For instance, treatments addressing procedural and surgical pain often require specialized formulations and administration methods to ensure rapid onset and sustained efficacy.

A further consideration in market segmentation is the method of administration. The spectrum of administration techniques covers oral, parenteral, and topical delivery mechanisms. Notably, the parenteral route is subdivided into intramuscular and intravenous methods, each with its own set of clinical indications and operational challenges. This segmentation is essential for aligning the delivery of therapies with the specific conditions of the animal, while also balancing factors such as ease of administration, bioavailability, and cost-effectiveness.

Lastly, segmentation by target species is crucial for tailoring pain relief products. The market analysis reveals distinct profiles across various species including cattle, poultry, sheep and goats, and swine. Different species not only display varied physiological responses to pain interventions but also require unique dosage forms and treatment regimens to ensure both safety and efficacy. This segmentation approach helps practitioners and product developers fine-tune treatment plans that are species-specific yet adaptable to the overarching demands of livestock management.

These segmentation insights underscore the complexity of the livestock pain relief market and the necessity for innovative, precise, and tailored solutions that meet the diverse requirements of stakeholders. Through a thorough understanding of these segments, companies and researchers can better navigate challenges and identify opportunities for growth and improvement in animal health.

Based on Type, market is studied across Acute Pain and Chronic Pain.

Based on Source, market is studied across Disease-Related Pain, Injury-Related Pain, Procedural Pain, and Surgical Pain.

Based on Method of Administration, market is studied across Oral, Parenteral, and Topical. The Parenteral is further studied across Intramuscular and Intravenous.

Based on Target Species, market is studied across Cattle, Poultry, Sheep & Goats, and Swine.

Key Regional Insights in Global Livestock Pain Management

In the realm of livestock pain management, geographical variations play a pivotal role in shaping market dynamics. Market behavior and demand are significantly influenced by factors such as local regulatory policies, economic conditions, and animal farming practices. The Americas have emerged as a robust market segment, driven by advanced healthcare systems and a strong emphasis on high welfare standards. Within this region, modernization of farming practices, coupled with proactive regulatory oversight, has bolstered the adoption of sophisticated pain management solutions.

In Europe, the Middle East, and Africa, stringent regulations and a heightened focus on animal welfare drive a steady increase in investments focused on pain relief and prevention. These regions have seen considerable advancements as government agencies and private organizations collaborate to enforce higher standards and stimulate innovation in animal health products. Outside the established economies, there is also significant growth in emerging markets as awareness of animal health and welfare continues to rise.

Asia-Pacific represents another dynamic region with unique challenges and opportunities. Rapid growth in the livestock sector, driven by increasing protein demand and expanding export markets, necessitates efficient strategies for managing pain and enhancing animal well-being. In this diverse region, traditional practices blend with modern biomedical insights, thereby creating fertile ground for innovations that can be adapted to local needs. Overall, the regional insights suggest that while the basic principles of pain management apply universally, tailored approaches are essential to meet specific regional requirements and market conditions.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation in Livestock Pain Relief

Market innovation in the fields of pain relief and prevention in livestock is propelled by several leading companies. Companies such as AdvaCare Pharma USA and Bimeda Holdings Limited are at the forefront, consistently advancing treatment options through rigorous R&D efforts and strategic partnerships. Boehringer Ingelheim International GmbH, known for its comprehensive portfolio, combines scientific expertise with market intelligence to facilitate the seamless integration of novel therapies into standard care protocols.

Cargill, Incorporated has been instrumental in bridging the gap between research and practical applications in farm management, while Ceva Sante Animale and Covetrus, Inc. continue to drive innovation by aligning product development with on-ground necessities. Dechra Pharmaceuticals Limited and Elanco Animal Health Incorporated further exemplify the industry's commitment to animal welfare by investing in both preventive and curative solutions that are backed by sound clinical research.

Other key players include HUVEPHARMA EOOD, IDEXX Laboratories, Inc., and Merck & Co., Inc., who have contributed significantly to the understanding of pain pathways and therapeutic interventions. Neogen Corporation, Norbrook Group, Patterson Vet Supply, Inc., and Phibro Animal Health Corporation have also made substantial impacts with next-generation products designed to optimize treatment efficacy. Vetoquinol S.A., Vetpro Healthcare, VIRBAC Animal Health India Private Ltd, and Zoetis Services LLC have established leadership positions by continuously pushing the envelope in research, formulation innovation, and global market strategy. Collectively, these companies represent a robust ecosystem wherein advanced research, efficient production, and strategic market deployment work in concert to revolutionize the management of pain in livestock.

The report delves into recent significant developments in the Pain Relief & Prevention in Livestock Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma USA, Bimeda Holdings Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals Limited, Elanco Animal Health Incorporated, HUVEPHARMA EOOD, IDEXX Laboratories, Inc, Merck & Co., Inc., Neogen Corporation, Norbrook Group, Patterson Vet Supply, Inc., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpro Healthcare, VIRBAC Animal Health India Private Ltd, and Zoetis Services LLC. Actionable Recommendations for Industry Leaders in Livestock Pain Management

Industry leaders are in a unique position to drive forward substantial improvements in the domain of livestock pain relief and prevention. First and foremost, investing in robust research and developmental activities is essential. Companies should focus on the cultivation of innovative therapies that are precisely targeted to distinct pain categories, be they acute or chronic. This emphasis on precision will help in addressing the underlying causes of pain, rather than just offering symptomatic relief.

It is important to leverage the growing insights derived from market segmentation. By integrating data on pain type, source, method of administration, and target species, decision-makers can tailor solutions that meet the specific requirements of various livestock segments. For instance, enhancing capabilities in developing products that are highly effective for disease-related pain or formulations optimized for different species can provide a significant competitive advantage in a diverse market.

Regional considerations must not be overlooked. Ignoring the regional nuances in regulation, consumer demand, and farming practices can lead to suboptimal outcomes. Industry leaders should customize their approaches based on economic conditions and local market maturity in areas such as the Americas, Europe, Middle East & Africa, and Asia-Pacific. This tailored strategy should be complemented by strong local partnerships and investments in regional research centers.

Fostering an ecosystem of collaboration between private enterprises, regulatory bodies, and academic institutions is another critical step forward. This collaboration is essential for fostering innovations that are both scientifically rigorous and commercially viable. Additionally, streamlining regulatory approvals and aligning product development with the latest compliance standards can expedite the market entry process and enhance consumer trust.

Finally, maintaining a customer-centric orientation by incorporating feedback from veterinarians, farmers, and other stakeholders can significantly improve product design and service delivery. Effective communication channels and customer engagement strategies will serve to bridge the gap between innovative solution offerings and the practical needs encountered on the ground. By following these recommendations, industry leaders can transform challenges into opportunities and establish a resilient framework for sustained growth in livestock pain management.

Conclusion: Summarizing Advancements in Livestock Pain Relief & Prevention

In summary, the landscape of pain relief and prevention in livestock is undergoing a profound transformation driven by scientific advancements, strategic segmentation, and a global shift towards higher animal welfare standards. The integration of cutting-edge research, targeted therapeutic approaches, and detailed market segmentation has redefined the way industry stakeholders approach pain management. With innovations spanning from acute to chronic pain treatments, and from varied sources such as disease, injury, procedural, and surgical origins, the market is evolving to meet the complex demands of modern farming practices.

Regionally, tailored solutions are emerging as local markets such as the Americas, Europe, Middle East & Africa, and Asia-Pacific display unique characteristics that influence both the demand for and the design of pain relief products. This convergence of global perspectives ensures that pain management practices are both scientifically advanced and deeply rooted in local realities. Meanwhile, leading companies are showcasing the benefits of a rigorous and innovative approach, which not only enhances the efficiency of treatments but also paves the way for sustainable and scalable solutions in animal health.

Ultimately, the current trends highlight an industry in transition - one that is steadily embracing innovation and precision, charting a course towards improved health outcomes for livestock and a more sustainable future for animal care worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for high-quality livestock products free from stress-induced illnesses
      • 5.1.1.2. Expanding livestock farming industry to meet the dietary needs of a growing global population
      • 5.1.1.3. Increasing awareness about animal welfare standards and ethical farming practices worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Varying regulations across different regions impacting product distribution
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovating smart diagnostic tools to ensure early detection and management of pain in livestock populations
      • 5.1.3.2. Leveraging natural and organic pain relief solutions to address health concerns in livestock
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in assessing and measuring pain levels in livestock complicates effective treatment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing acute pain in livestock contribute the need for fast-acting analgesics or local anesthetics
    • 5.2.2. Target Species: Rising pain management in poultry due to welfare concerns related to practices such as beak trimming and transport stress
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pain Relief & Prevention in Livestock Market, by Type

  • 6.1. Introduction
  • 6.2. Acute Pain
  • 6.3. Chronic Pain

7. Pain Relief & Prevention in Livestock Market, by Source

  • 7.1. Introduction
  • 7.2. Disease-Related Pain
  • 7.3. Injury-Related Pain
  • 7.4. Procedural Pain
  • 7.5. Surgical Pain

8. Pain Relief & Prevention in Livestock Market, by Method of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
    • 8.3.1. Intramuscular
    • 8.3.2. Intravenous
  • 8.4. Topical

9. Pain Relief & Prevention in Livestock Market, by Target Species

  • 9.1. Introduction
  • 9.2. Cattle
  • 9.3. Poultry
  • 9.4. Sheep & Goats
  • 9.5. Swine

10. Americas Pain Relief & Prevention in Livestock Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pain Relief & Prevention in Livestock Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pain Relief & Prevention in Livestock Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Lidocaine infused bands minimize castration discomfort for young calves
    • 13.3.2. Dopharma launches Dophacyl Avi for poultry pain relief
    • 13.3.3. Panav Biotech launches Maropitine injection
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AdvaCare Pharma USA
  • 2. Bimeda Holdings Limited
  • 3. Boehringer Ingelheim International GmbH
  • 4. Cargill, Incorporated
  • 5. Ceva Sante Animale
  • 6. Covetrus, Inc.
  • 7. Dechra Pharmaceuticals Limited
  • 8. Elanco Animal Health Incorporated
  • 9. HUVEPHARMA EOOD
  • 10. IDEXX Laboratories, Inc
  • 11. Merck & Co., Inc.
  • 12. Neogen Corporation
  • 13. Norbrook Group
  • 14. Patterson Vet Supply, Inc.
  • 15. Phibro Animal Health Corporation
  • 16. Vetoquinol S.A.
  • 17. Vetpro Healthcare
  • 18. VIRBAC Animal Health India Private Ltd
  • 19. Zoetis Services LLC

LIST OF FIGURES

  • FIGURE 1. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET MULTI-CURRENCY
  • FIGURE 2. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET MULTI-LANGUAGE
  • FIGURE 3. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET RESEARCH PROCESS
  • FIGURE 4. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET DYNAMICS
  • TABLE 7. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY DISEASE-RELATED PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY INJURY-RELATED PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PROCEDURAL PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SURGICAL PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SIZE, BY TARGET SPECIES, 2018-2030 (USD MILLION)
  • TABLE 236. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 237. PAIN RELIEF & PREVENTION IN LIVESTOCK MARKET, FPNV POSITIONING MATRIX, 2024